Results 71 to 80 of about 69,966 (266)
Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
Background Nucleoside analogues (NAs) such as entecavir are required for at least 12 months when patients with resolved hepatitis B virus (HBV) infection develop HBV reactivation.
Maki Ohkubo +3 more
doaj +1 more source
HBV DNA replication in Hep-Y1 cells after HBV infection.
(A) Southern blot kinetic analysis of PCR products after infection of Hep-Y1 cells with control normal HBV-negative serum and HBV-containing serum. P1 and P2, 1 pg and 50 pg of PCR products derived from HBV DNA were loaded. (B) Quantification of HBV DNA.
Chih-Lang Lin (586444) +5 more
core +1 more source
Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium
In recent years, incorporating comprehensive cancer screening strategies into routine HIV care has gained growing attention. This survey of 220 sites providing HIV care across 41 countries shows that cervical cancer screening has increased in availability over time.
Rachael A. Pellegrino +32 more
wiley +1 more source
Objectives: To unravel the still unexplored HBV-replicative kinetics in anti-HBc-positive/HBsAg-negative people-with-HIV (PWH) suspending tenofovir disoproxil-fumarate/tenofovir-alafenamide (TDF/TAF).
Romina Salpini +16 more
doaj +1 more source
HBV Infection in Human Hepatocytes and Quantification of Encapsidated HBV DNA
Human hepatic cancer cell lines such as HepG2, Huh7, and HLE cannot get infected with Hepatitis B virus (HBV) due to lack of an HBV receptor(s). Transfection with HBV genome has so far been referred as a tool to mimic HBV infection. However, since sodium taurocholate cotransporting polypeptide (NTCP) was identified as a functional receptor for HBV (Yan
Kai Li, Seiichi Sato, Akinori Takaoka
openaire +2 more sources
Quantitation of HBV covalently closed circular DNA (HBV CCC DNA) in HCC patients
Objective: Hepatitis B virus (HBV) is a major causative agent of hepatocellular carcinoma (HCC). We aimed to use the Invader assay to measure the intrahepatic total HBV DNA and covalently closed circular (ccc) DNA in the tumorous and non-tumorous ...
Poon, RTP +4 more
core +1 more source
While several oncogenic pathogens cause site‐specific cancers, uncertainties remain about many other chronic infections and combined pathogen effects, especially in non‐Western populations. Using a large case–cohort study nested within the China Kadoorie Biobank, the authors found that co‐infection was common, with a mean of 10 pathogens per individual.
Ling Yang +212 more
wiley +1 more source
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery
Hepatitis B virus (HBV), which was discovered in 1965, is a threat to global public health. HBV infects human hepatocytes and leads to acute and chronic liver diseases, and there is no cure.
Kaitao Zhao, Andrew Liu, Yuchen Xia
doaj +1 more source
Quantitation of circulating hepatitis B virus (HBV) DNA is important for monitoring disease progression and for assessing the response to antiviral therapy. Several commercial and 'in house' assays for HBV DNA quantitation have been described but many of
Tedder, RS +4 more
core
Correlation between intrahepatic HBV cccDNA and HBV total DNA or serum HBV DNA.
A significant correlation was observed between total intrahepatic cccDNA levels and HBV DNA (panel A), but not for serum HBV DNA level (panel B) among 35 HCC patients with detectable cccDNA in paired samples.
Yanmeng Chen (2839214) +7 more
core +1 more source

